Uses of Plagerine A 150 mg/75 mg Capsule
Plagerine A 150 mg/75 mg Capsule is used for the treatment or prevention of the following disease(s):
Pain, Fever
Side effects of Plagerine A 150 mg/75 mg Capsule
Precautions while taking Plagerine A 150 mg/75 mg Capsule
Dosage of Plagerine A 150 mg/75 mg Capsule
Overdose of Plagerine A 150 mg/75 mg Capsule
Onset of Action of Plagerine A 150 mg/75 mg Capsule
Duration of Action of Plagerine A 150 mg/75 mg Capsule
Precautions & Warnings
Alcohol
Information will be added soon.
Pregnancy
Information will be added soon.
Breastfeeding
Information will be added soon.
Driving
Information will be added soon.
Kidney
Information will be added soon.
Liver
Information will be added soon.
All substitutes for Plagerine A 150 mg/75 mg Capsule
For information purpose only. Refer to a healthcare professionals before consuming any medicines and/or drugs.
Interactions
Drug :-
ACE inhibitors:
May decrease antihypertensive effects. Monitor BP closely.
Acetazolamide:
May cause accumulation and toxicity of acetazolamide, resulting in CNS depression,
metabolic acidosis, anorexia, and death. Administer together with caution and monitor patient for
toxicity.
Ammonium chloride and other urine acidifiers:
May increase levels of aspirin products. Watch for
aspirin toxicity.
Antacids in high doses and other urine alkalinizers:
May decrease levels of aspirin products. Watch
for decreased aspirin effect.
Anticoagulants, antiplatelet agents:
May increase risk of bleeding. Use with extreme caution if these
drugs must be used together.
Beta blockers:
May decrease antihypertensive effect. Avoid long-term aspirin use if patient is taking
antihypertensives.
Corticosteroids:
May enhance salicylate elimination and decrease drug level. Watch for decreased
aspirin effect.
Diuretics:
May decrease effectiveness of diuretics in patients with underlying renal or CV disease.
Monitor patient for effectiveness.
Heparin:
May increase risk of bleeding. Monitor coagulation studies and patient closely if used
together.
Ibuprofen, other NSAIDs:
May negate the antiplatelet effect of low-dose aspirin therapy. Patients
using immediate-release aspirin (not enteric-coated) should take ibuprofen at least 30 minutes after or
more than 8 hours before aspirin. Occasional use of ibuprofen is unlikely to have a negative effect.
Influenza virus vaccine, live:
Increased risk of Reye syndrome. Use together is contraindicated in
children and adolescents.
Methotrexate:
May increase risk of methotrexate toxicity. Avoid using together.
Oral antidiabetics:
May increase hypoglycemic effect. Monitor patient closely.
Probenecid, sulfinpyrazone:
May decrease uricosuric effect. Avoid using together.
Valproic acid:
May increase valproic acid level. Avoid using together.
Herb :-
White willow:
Contains salicylates and may increase risk of adverse effects. Discourage
use together.
Food :-
Caffeine:
May increase drug absorption. Watch for increased effects.